#drug development

Alzheimer's Drug Lecanemab Shows 27% Cognitive Decline Reduction in Major Clinical Trial

Lecanemab shows 27% reduction in cognitive decline for early Alzheimer's patients. The breakthrough could transform dementia treatment worldwide.

• #alzheimers
• #clinical trials
• #neuroscience
• #drug development